ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,864.67
0.40%
US Tech 100
19,784.00
0.68%
Dow Jones
43,275.91
0.09%
Brent Oil
72.935
0.00%
Bitcoin
68,335.54
-0.13%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Oasmia Pharmaceuticals AB (OASM) Quote

Oasmia Pharmaceuticals AB

Oasmia Pharmaceuticals AB (OASM)

NASDAQ
1.55
0.00
(0.00%)
Closed October 18 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.55
Bid
1.01
Ask
2.14
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
833.967M
Previous Close
1.55
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
538,043,000
Dividend Yield
-
PE Ratio
-21.77
Earnings Per Share (EPS)
-0.24
Revenue
9.5M
Net Profit
-128.74M

About Oasmia Pharmaceuticals AB

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved pro... Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells a new generation of drugs within human and veterinary oncology. It focuses on the development of manufacturing activity of novel formulations based on cytostatic which shows improved properties, a reduced side-effect profile, and an expanded therapeutic area. The products and product candidates utilize a proprietary, nanoparticle formulation technology that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients, without the addition of toxic solvents. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.vivesto.com
Headquarters
Uppsala, Swe
Founded
-

Ask ADVFN Intelligence (AI)

OASM Latest News

More News

CORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction

Creating a Scaled Unconventional U.S. Oil Producer with a Premier Williston Basin Acreage Position Totaling 972K Net Acres and Combined 4Q21 Production of 167.8 Thousand Boepd Transaction...

March 07 2022
Business Wire

Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction

Creating a Scaled Unconventional U.S. Oil Producer with a Premier Williston Basin Acreage Position Totaling 972K Net Acres and Combined 4Q21 Production of 167.8 Thousand Boepd Transaction...

March 07 2022
Business Wire

New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted

Oasmia Pharmaceutical AB (Nasdaq: OASM) announces that the United States Patent and Trademark Office (USPTO) has issued a notification of allowance of a patent for its unique nanotech method to...

November 20 2018
GlobeNewswire Inc.

Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma

Overall response rate data from the (RXE) Phase II study conducted in the US and Sweden met its primary end points and treatment with Doxophos Vet was generally well tolerated. Oasmia’s...

October 03 2018
GlobeNewswire Inc.

Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union

Apealea receives positive CHMP opinion in the European Union for treatment of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer in combination with...

September 21 2018
GlobeNewswire Inc.

Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today that it has received marketing approval of Doxophos in...

August 08 2017
GlobeNewswire Inc.

Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets

Oasmia Pharmaceutical AB (NASDAQ: OASM) has entered into a new exclusive marketing and distributions agreement with Hetero Group (Hetero) with the goal of driving revenue in Russia and other...

June 14 2017
GlobeNewswire Inc.

Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets

Oasmia Pharmaceutical AB (NASDAQ: OASM) has entered into a new exclusive marketing and distributions agreement with Hetero Group (Hetero) with the goal of driving revenue in Russia and other...

June 14 2017
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRUGBright Minds Biosciences Inc
$ 47.37
(118.29%)
27.24M
BIVIBioVie Inc
$ 2.3304
(108.07%)
52.28M
HEPSD Market Electronic Services and Trading
$ 3.52
(60.00%)
43.86M
LTBRLightbridge Corporation
$ 6.98
(56.85%)
7.71M
PEGYPineapple Energy Inc
$ 8.19
(48.64%)
31.69M
NKGNNKGen Biotech Inc
$ 0.3974
(-43.23%)
5.06M
ORGSOrgenesis Inc
$ 2.1001
(-35.14%)
486.29k
BIAFbioAffinity Technologies Inc
$ 1.40
(-34.27%)
1.45M
VEVVicinity Motor Corporation
$ 0.0466
(-31.27%)
37.45M
CETXCemtrex Inc
$ 0.299
(-27.07%)
20.69M
JTAIJet AI Inc
$ 0.1008
(4.02%)
347.37M
NVDANVIDIA Corporation
$ 138.00
(0.78%)
175.78M
SQQQProShares UltraPro Short QQQ
$ 7.13
(-1.79%)
105.75M
TVGNTevogen Bio Holdings Inc
$ 1.72
(24.64%)
101.26M
LCIDLucid Group Inc
$ 2.625
(-2.42%)
80.88M

Discussion

View Full Feed
JonDoe1 JonDoe1 4 minutes ago
Legit like saying the note was negotiated and a share buyback was happening? Legit companies don't put out PRs like that and not follow through. How about the crypto token scam? How about Benny aka Pinkpanther aka Momoraptor pumping SRGE and CRGP? Pumpers such as yourself fail to address his previou
CRGP
delerious1 delerious1 6 minutes ago
Too bad the zero share basher clowns won't turn their time and talents around to something positive like picking winners I would be a fan
NBRI
Kojacky Kojacky 6 minutes ago
It’s coming.
RDAR
waterchaser waterchaser 7 minutes ago
Yes, mojo picked “$70’s as a gift”.
How is it he’s the only DJT trader able to pick these unbelievable great buys?
He’s genius.
They just can't pick the exact lows and highs like you do.... LOL LOL
DJT
rocioyogi rocioyogi 7 minutes ago
Yes, buyout without a doubt definitely the question is whether a cash buyout or a stock trade buyout in other words Pfizer if we sell to Pfizer hypothetically say we got $3.50 a share we would get equal value for how many shares that equals in Pfizer, then you’re not paying capital gains tax on that
ELTP
Eagle1 Eagle1 7 minutes ago
Hope Everyone is good. OTC is coming back.
GDVM
$theDDmessiah $theDDmessiah 7 minutes ago
Yeah takes a littler more time peopke scratching their heads still lol
RDAR
KeepItRealistic KeepItRealistic 8 minutes ago
$MGRX if company captures only 1/10th of one percent of that market, it gives you $49.3m in Revenues 😮

Let that SINK IN …

https://finance.yahoo.com/news/mangorx-addresses-49-3-billion-113000298.html
MGRX
Controlledoilandgas Controlledoilandgas 8 minutes ago
Yes - aiming for Monday
AZRH
Multi-Bagger Multi-Bagger 9 minutes ago
Looks like News posted on IG. Do you think they release it on news outlets Monday or next week. Waiting for the filings to be uploaded on otcmarkets and news
AZRH
Green doggie Green doggie 9 minutes ago
Resignation of Registered Agent on 10/15/24 per filing at Nevada Secretary of State
EGOC
4u2nv2 4u2nv2 10 minutes ago
Yoga and deep breathing exercises could help you with the stress of being so concerned about why I picked MCIC for my watchlist!!!!!
MCIC
Dorick Dorick 10 minutes ago
I allege that Quantum Energy Inc has violated the Exchange Act and the Securities Act in that Quantum Energy has made use of deceptive and fraudulent contrivances, devices, schemes, and artifices, has made materially untrue statements, has omitted to reveal highly material facts, and has engaged in
FLCX
jbsliverer jbsliverer 10 minutes ago
Interesting.

Alex Spahn 🌋🌪️☄️
?@spahn711.bsky.social?
BlueSky is now the 5th biggest social media platform on the Google Play Store, having surpassed Twitter. Onward and upward! 👀


https://cdn.bsky.app/img/feed_thumbnail/plai
renaissance1 renaissance1 12 minutes ago
Hello all. New to this ticker. Where is the 350M rev coming from. Took a starter two days ago. Good luck to everyone here. Thanks in advance
RDAR
HGilS HGilS 13 minutes ago
Nasrat only option to cash out all his shares is buyout.
ELTP
Multi-Bagger Multi-Bagger 14 minutes ago
Merger and name change. Lot of things in the pipeline news wise
AZRH
jour_trader jour_trader 14 minutes ago
Yes, generic Perc launches next around mid-Nov. 
ELTP
CryptoRain CryptoRain 15 minutes ago
Yes for sure. That would solidify things
HIRU
OMOLIVES OMOLIVES 16 minutes ago
So was Benedict Arnold and George Armstrong Custer. I never enlisted, therefor never a soldier.
newmedman newmedman 16 minutes ago
I'm glad it's funny to you.

it makes no difference giving what is coming down the pipe economically and geopolitically

what exactly are the issues you speak of Mr. wizard?
Jimmy Joe Jimmy Joe 16 minutes ago
Hope you're right rocioyogi. That would be a very nice option.
ELTP
DKLN DKLN 16 minutes ago
This is not about me. This is about you praising, for years, a trainwreck of a stock and now not wanting to address why you were so wrong. There is no need to lash out at people who have called this stock accurately. Instead, why don't you tell the Board why you thought this stock/"company" was wort
MCIC

Your Recent History

NASDAQ
OASM
Oasmia Pharmaceuticals AB
TSX
FCUD
Fidelity US High Dividen...
TSX
RNW
TransAlta Renewables
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved